HRSA Newborn Screening
HRSA’s Newborn Screening Information Center (NBSIC) provides clear and up-to-date information, materials, and resources about NBS in the United States
The Connecticut Newborn Screening Program
Fatty Acid Oxidation Disorders
Fatty Acid Oxidation (FAO) Disorders can affect the body’s metabolism. The body cannot break down fats to turn into energy. If fatty acids are not broken down, they can cause harm to important organs such as the heart and liver. If infants with these disorders go too long without eating, they can experience serious health problems. Treatment can include a special diet, frequent feedings, and medications.
Core Conditions
Carnitine Uptake Defect (CUD)
Long-Chain L-3 Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD)
Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)
Trifunctional Protein Deficiency (TFP)
Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD)
Secondary Conditions
2,4 Dienoyl-CoA Reductase Deficiency (DE RED)
Carnitine Acylcarnitine Translocase Deficiency (CACT)
Carnitine Palmitoyltransferase I Deficiency (CPT I)
Carnitine Palmitoyltransferase Type II Deficiency (CPT II)
Glutaric Acidemia, Type II (GA 2)
Medium/Short-Chain L-3 Hydroxyacyl-CoA Dehydrogenase Deficiency (M/SCHAD)
Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD)